Theriva Biologics, Inc. (TOVX)
USD 1.17
(-0.29%)
USD 1.17
(-0.29%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -28.49 USD | 11.27% |
| 2022 | -32.11 USD | -2668.1% |
| 2021 | -1.16 USD | 77.95% |
| 2020 | -5.26 USD | 42.45% |
| 2019 | -9.14 USD | 57.39% |
| 2018 | -21.45 USD | 49.77% |
| 2017 | -42.70 USD | 57.79% |
| 2016 | -101.17 USD | 46.66% |
| 2015 | -189.68 USD | -69.69% |
| 2014 | -111.78 USD | -18.41% |
| 2013 | -94.40 USD | 44.86% |
| 2012 | -171.19 USD | -66.32% |
| 2011 | -102.93 USD | -284.79% |
| 2010 | -26.75 USD | 56.33% |
| 2009 | -61.26 USD | 49.84% |
| 2008 | -122.12 USD | 37.93% |
| 2007 | -196.76 USD | 55.51% |
| 2006 | -442.24 USD | 54.99% |
| 2005 | -982.49 USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -10.72 USD | 94.29% |
| 2024 Q1 | -7.53 USD | 5.88% |
| 2023 Q4 | -8.00 USD | -64.95% |
| 2023 Q3 | -4.85 USD | 42.12% |
| 2023 Q1 | -7.40 USD | 16.76% |
| 2023 Q2 | -8.38 USD | -13.24% |
| 2023 FY | - USD | 11.3% |
| 2022 Q4 | -8.89 USD | -2863.33% |
| 2022 Q3 | -0.30 USD | 3.23% |
| 2022 Q2 | -0.31 USD | 0.0% |
| 2022 Q1 | -0.31 USD | 22.5% |
| 2022 FY | - USD | -2668.1% |
| 2021 Q4 | -0.40 USD | -60.0% |
| 2021 FY | - USD | 77.95% |
| 2021 Q1 | -0.28 USD | 72.0% |
| 2021 Q2 | -0.24 USD | 14.29% |
| 2021 Q3 | -0.25 USD | -4.17% |
| 2020 FY | - USD | 42.45% |
| 2020 Q1 | -1.73 USD | 7.49% |
| 2020 Q2 | -1.56 USD | 9.83% |
| 2020 Q3 | -1.08 USD | 30.77% |
| 2020 Q4 | -1.00 USD | 7.41% |
| 2019 Q2 | -2.14 USD | 4.46% |
| 2019 Q4 | -1.87 USD | 38.69% |
| 2019 Q3 | -3.05 USD | -42.52% |
| 2019 FY | - USD | 57.39% |
| 2019 Q1 | -2.24 USD | -9.27% |
| 2018 Q2 | -11.39 USD | -80.79% |
| 2018 Q1 | -6.30 USD | -181.82% |
| 2018 Q3 | -9.14 USD | 19.75% |
| 2018 FY | - USD | 49.77% |
| 2018 Q4 | -2.05 USD | 77.57% |
| 2017 Q3 | -29.80 USD | -146.08% |
| 2017 Q1 | -8.48 USD | -6.0% |
| 2017 Q4 | 7.70 USD | 125.84% |
| 2017 FY | - USD | 57.79% |
| 2017 Q2 | -12.11 USD | -42.81% |
| 2016 Q4 | -8.00 USD | 74.98% |
| 2016 Q1 | -41.79 USD | 1.16% |
| 2016 Q2 | -21.85 USD | 47.71% |
| 2016 Q3 | -31.97 USD | -46.32% |
| 2016 FY | - USD | 46.66% |
| 2015 Q3 | -27.58 USD | 57.93% |
| 2015 Q2 | -65.55 USD | -10.13% |
| 2015 Q1 | -59.52 USD | -90.83% |
| 2015 FY | - USD | -69.69% |
| 2015 Q4 | -42.28 USD | -53.3% |
| 2014 Q2 | -27.28 USD | -18.45% |
| 2014 Q1 | -23.03 USD | 24.04% |
| 2014 Q4 | -31.19 USD | -6.09% |
| 2014 FY | - USD | -18.41% |
| 2014 Q3 | -29.40 USD | -7.77% |
| 2013 FY | - USD | 44.86% |
| 2013 Q3 | -26.40 USD | -34.9% |
| 2013 Q4 | -30.32 USD | -14.85% |
| 2013 Q1 | -17.48 USD | 82.95% |
| 2013 Q2 | -19.57 USD | -11.96% |
| 2012 Q3 | -20.24 USD | -1.96% |
| 2012 Q4 | -102.55 USD | -406.67% |
| 2012 FY | - USD | -66.32% |
| 2012 Q2 | -19.85 USD | -51.3% |
| 2012 Q1 | -13.12 USD | 65.14% |
| 2011 Q1 | -30.34 USD | -131.96% |
| 2011 Q2 | -21.09 USD | 30.49% |
| 2011 Q3 | -13.68 USD | 35.14% |
| 2011 Q4 | -37.64 USD | -175.15% |
| 2011 FY | - USD | -284.79% |
| 2010 Q1 | -17.65 USD | 2.92% |
| 2010 FY | - USD | 56.33% |
| 2010 Q2 | 17.50 USD | 199.15% |
| 2010 Q4 | -13.08 USD | -17.31% |
| 2010 Q3 | -11.15 USD | -163.71% |
| 2009 Q3 | -10.22 USD | 29.27% |
| 2009 FY | - USD | 49.84% |
| 2009 Q2 | -14.45 USD | 22.69% |
| 2009 Q1 | -18.69 USD | -21.6% |
| 2009 Q4 | -18.18 USD | -77.89% |
| 2008 FY | - USD | 37.93% |
| 2008 Q2 | -30.12 USD | 43.02% |
| 2008 Q4 | -15.37 USD | 36.33% |
| 2008 Q3 | -24.14 USD | 19.85% |
| 2008 Q1 | -52.86 USD | 7.94% |
| 2007 Q3 | -43.39 USD | -19.76% |
| 2007 Q1 | -176.22 USD | -109.04% |
| 2007 Q2 | -36.23 USD | 79.44% |
| 2007 FY | - USD | 55.51% |
| 2007 Q4 | -57.42 USD | -32.33% |
| 2006 Q1 | -344.38 USD | 0.0% |
| 2006 Q2 | -0.97 USD | 99.72% |
| 2006 Q3 | -0.69 USD | 28.87% |
| 2006 FY | - USD | 54.99% |
| 2006 Q4 | -84.30 USD | -12117.39% |
| 2005 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 100.0% |
| 2001 Q1 | -659.60 USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q1 | -16.96 USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q2 | - USD | 100.0% |